Kopra Bio develops viral immunotherapy treatments for aggressive cancers, like glioblastoma. Our technology, developed at UCSF, has shown incredible promise in preclinical models, increasing survival from 0% to 90%. Learn more about our mission to revolutionize cancer treatment.
Kopra Bio is a cancer immunotherapy that turns cancer cells into biofactories that produce their own destruction.
The treatment is aimed at cancer patients and healthcare professionals.